Hamada, Y.; Kasai, H.; Suzuki-Ito, M.; Matsumura, Y.; Doi, Y.; Hayakawa, K.
Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales in Patients with Invasive Urinary Tract Infection Considering Renal Function. Antibiotics 2022, 11, 456.
https://doi.org/10.3390/antibiotics11040456
AMA Style
Hamada Y, Kasai H, Suzuki-Ito M, Matsumura Y, Doi Y, Hayakawa K.
Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales in Patients with Invasive Urinary Tract Infection Considering Renal Function. Antibiotics. 2022; 11(4):456.
https://doi.org/10.3390/antibiotics11040456
Chicago/Turabian Style
Hamada, Yukihiro, Hidefumi Kasai, Moeko Suzuki-Ito, Yasufumi Matsumura, Yohei Doi, and Kayoko Hayakawa.
2022. "Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales in Patients with Invasive Urinary Tract Infection Considering Renal Function" Antibiotics 11, no. 4: 456.
https://doi.org/10.3390/antibiotics11040456
APA Style
Hamada, Y., Kasai, H., Suzuki-Ito, M., Matsumura, Y., Doi, Y., & Hayakawa, K.
(2022). Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales in Patients with Invasive Urinary Tract Infection Considering Renal Function. Antibiotics, 11(4), 456.
https://doi.org/10.3390/antibiotics11040456
